Currency in GBP

Last close As at 09/12/2023


0.00 (0.00%)

Market capitalisation


EMIS is a software supplier to the UK healthcare market. EMIS Health supplies integrated care technology to the NHS, including primary, community, acute and social care. EMIS Enterprise is a B2B software provider to the healthcare market, including medicines management, partner businesses, patient-facing services and healthcare analytics.

For the purposes of the Takeover Code, Edison is deemed to be connected with EMIS as a provider of paid-for research. Under Rule 20.1 Edison must not include any profit forecast, quantified financial benefits statement, asset valuation or estimate of other figures key to the offer, except to the extent that such forecasts, statements, valuations or estimates have been published prior to the offer period (as defined in the Takeover Code) by an offeror or the offeree company (as appropriate) in accordance with the requirements of the Code. Consequently we have removed our estimates until the offer period ends.

Latest Insights

View More

TMT | Flash note

EMIS Group — CMA provisionally clears takeover of EMIS

TMT | Update

EMIS Group — FY22 results in line



Equity Analyst

Key Management

  • Andy Thorburn


  • Peter Southby


Balance Sheet

Forecast net debt (£m)


Forecast gearing ratio (%)


Share Price Performance

Price Performance
% 1M 3M 12M
Actual (0.6) 32.2 3.3
Relative 3.7 40.4 1.3
52 week high/low 1934.0p/1310.0p


The Competition and Markets Authority (CMA) has given final approval to the takeover of EMIS by UnitedHealth. Subject to the scheme receiving the approval of the court at the sanction hearing on 25 October, the takeover is expected to complete on 27 October. On 23 October EMIS will pay the recently proposed interim dividend to shareholders on the register on 6 October without reducing the acquisition cash consideration.

Y/E Dec Revenue (£m) EBITDA (£m) PBT (£m) EPS (fd) (p) P/E (x) P/CF (x)
2021A 168.2 54.7 43.5 55.0 34.9 24.2
2022A 175.4 59.4 48.1 60.9 31.5 24.8
2023E N/A N/A N/A N/A N/A N/A
2024E N/A N/A N/A N/A N/A N/A




MediaWatch – November 2023: Still waiting…



MediaWatch – July 2023

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free